Spindler Kurt P, Murray Martha M, Carey James L, Zurakowski David, Fleming Braden C
Vanderbilt Sports Medicine, Department of Orthopaedics and Rehabilitation, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
J Orthop Res. 2009 May;27(5):631-8. doi: 10.1002/jor.20785.
Many anterior cruciate ligament (ACL) reconstructions have increased laxity postoperatively. We hypothesized that enhancing an ACL graft with a collagen-platelet composite (CPC) would improve knee laxity and graft structural properties. We also hypothesized the platelet concentration in the CPC would affect these parameters. Twelve goats underwent ACL reconstruction with autologous patellar tendon graft. In six goats, a collagen-platelet composite was placed around the graft (CPC group). In the remaining six goats, the collagen scaffold only was used (COLL group). Three goats were excluded due to complications. After 6 weeks in vivo, anterior-posterior (AP) laxity and tensile properties of the ACL reconstructed knees were measured and normalized against the contralateral intact knee. At a knee flexion angle of 30 degrees, the average increase in AP laxity was 40% less in the CPC group than the COLL group (p = 0.045). At 60 degrees, the AP laxity was 30% less in the CPC group, a difference that was close to statistical significance (p = 0.080). No differences were found between treatment groups with respect to the structural properties (p > 0.30). However, there were significant correlations between serum platelet concentration and AP laxity (R2 = 0.643; p = 0.009), maximum load (R2 = 0.691; p = 0.006), and graft stiffness (R2 = 0.840; p < 0.001). In conclusion, use of a CPC to enhance healing of an allograft ACL reconstruction inversely correlated with early sagittal plane laxity and the systemic platelet count was highly predictive of ACL reconstruction graft strength and stiffness at 6 weeks. These findings emphasize the importance of further research on delineating the effect of platelets in treating of ACL injuries.
许多前交叉韧带(ACL)重建术后膝关节松弛度增加。我们假设用胶原蛋白-血小板复合物(CPC)增强ACL移植物可改善膝关节松弛度和移植物的结构特性。我们还假设CPC中的血小板浓度会影响这些参数。12只山羊接受了自体髌腱移植的ACL重建。6只山羊的移植物周围放置了胶原蛋白-血小板复合物(CPC组)。其余6只山羊仅使用了胶原蛋白支架(COLL组)。3只山羊因并发症被排除。体内6周后,测量ACL重建膝关节的前后(AP)松弛度和拉伸特性,并与对侧完整膝关节进行标准化比较。在膝关节屈曲30度时,CPC组的AP松弛度平均增加量比COLL组少40%(p = 0.045)。在60度时,CPC组的AP松弛度少30%,这一差异接近统计学显著性(p = 0.080)。治疗组之间在结构特性方面未发现差异(p > 0.30)。然而,血清血小板浓度与AP松弛度(R2 = 0.643;p = 0.009)、最大负荷(R2 = 0.691;p = 0.006)和移植物刚度(R2 = 0.840;p < 0.001)之间存在显著相关性。总之,使用CPC增强同种异体ACL重建的愈合与早期矢状面松弛度呈负相关,全身血小板计数可高度预测6周时ACL重建移植物的强度和刚度。这些发现强调了进一步研究血小板在治疗ACL损伤中的作用的重要性。